Horizon Therapeutics PLC (NASDAQ:HZNP)
| 89.71 BATS BZX Real-Time Price As of 10:54am ET |  +1.25 / +1.41%Today’s Change | 82.51 Today|||52-Week Range 120.54 | -16.75% Year-to-Date |
Latest HZNP News | Press Releases
| Stock Market Sell-Off: 4 Bargain Stocks Begging to Be Bought May 20 / StockNews.com - Paid Partner Content | Horizon (HZNP) Begins Enrollment in Alopecia Areata Study May 18 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 88.46 |
| Today’s open | 88.38 |
| Day’s range | 88.38 - 90.13 |
| Volume | 17,306 |
| Average volume (3 months) | 1,854,924 |
| Market cap | $20.8B |
Data as of 10:54am ET, 05/26/2022
Growth & Valuation
| Earnings growth (last year) | +24.00% |
| Earnings growth (this year) | +28.75% |
| Earnings growth (next 5 years) | +14.67% |
| Revenue growth (last year) | +46.63% |
| P/E ratio | 24.3 |
| Price/Sales | 7.87 |
| Price/Book | 4.40 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CTLTCatalent Inc | +1.76 | +1.82% |
| INCYIncyte Corp | +0.64 | +0.84% |
| SGENSeagen Inc | +1.46 | +1.07% |
| ALNYAlnylam Pharmaceutic... | +0.65 | +0.51% |
Data as of 10:54am ET, 05/26/2022
Financials
| Next reporting date | August 10, 2022 |
| EPS forecast (this quarter) | $1.34 |
| Annual revenue (last year) | $3.2B |
| Annual profit (last year) | $534.5M |
| Net profit margin | 16.57% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Dublin, Dublin |
Forecasts
